NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,406,270 | -10.2% | 377,049 | -10.9% | 0.01% | 0.0% |
| Q2 2023 | $42,752,731 | +12.3% | 423,387 | +2.3% | 0.01% | +8.3% |
| Q1 2023 | $38,072,578 | -26.2% | 413,755 | -27.2% | 0.01% | -33.3% |
| Q4 2022 | $51,555,000 | +5.2% | 568,297 | -11.8% | 0.02% | 0.0% |
| Q3 2022 | $49,003,000 | -18.4% | 644,687 | -9.3% | 0.02% | -14.3% |
| Q2 2022 | $60,084,000 | -53.6% | 710,780 | -51.9% | 0.02% | -44.7% |
| Q1 2022 | $129,610,000 | +9.9% | 1,477,047 | +9.6% | 0.04% | +15.2% |
| Q4 2021 | $117,921,000 | +1.9% | 1,348,037 | -4.7% | 0.03% | -10.8% |
| Q3 2021 | $115,714,000 | -26.6% | 1,414,988 | -18.2% | 0.04% | -24.5% |
| Q2 2021 | $157,738,000 | +7.0% | 1,728,787 | +0.2% | 0.05% | 0.0% |
| Q1 2021 | $147,453,000 | -10.9% | 1,725,168 | -1.6% | 0.05% | -16.9% |
| Q4 2020 | $165,560,000 | +70.5% | 1,753,150 | +57.2% | 0.06% | +51.3% |
| Q3 2020 | $97,102,000 | -4.9% | 1,115,302 | -4.6% | 0.04% | -11.4% |
| Q2 2020 | $102,053,000 | +2.6% | 1,168,815 | -3.1% | 0.04% | -15.4% |
| Q1 2020 | $99,424,000 | -13.2% | 1,206,815 | -0.3% | 0.05% | +8.3% |
| Q4 2019 | $114,584,000 | +28.4% | 1,210,374 | +17.9% | 0.05% | +20.0% |
| Q3 2019 | $89,234,000 | -7.4% | 1,026,814 | -2.7% | 0.04% | -7.0% |
| Q2 2019 | $96,348,000 | -5.3% | 1,055,115 | -0.3% | 0.04% | -8.5% |
| Q1 2019 | $101,704,000 | +13.2% | 1,057,864 | +1.1% | 0.05% | +4.4% |
| Q4 2018 | $89,806,000 | -15.3% | 1,046,693 | +6.7% | 0.04% | +21.6% |
| Q3 2018 | $106,011,000 | +51.2% | 980,593 | +5.7% | 0.04% | +19.4% |
| Q2 2018 | $70,090,000 | -4.3% | 927,977 | +2.6% | 0.03% | -6.1% |
| Q1 2018 | $73,229,000 | -8.9% | 904,399 | -5.6% | 0.03% | -10.8% |
| Q4 2017 | $80,402,000 | -4.4% | 958,106 | -2.2% | 0.04% | -7.5% |
| Q3 2017 | $84,135,000 | +0.6% | 980,123 | -2.2% | 0.04% | -4.8% |
| Q2 2017 | $83,629,000 | -6.8% | 1,002,087 | -17.0% | 0.04% | -8.7% |
| Q1 2017 | $89,759,000 | -12.0% | 1,207,916 | -13.8% | 0.05% | -17.9% |
| Q4 2016 | $102,044,000 | -10.1% | 1,400,993 | -2.5% | 0.06% | -12.5% |
| Q3 2016 | $113,482,000 | -5.7% | 1,437,238 | -1.6% | 0.06% | -9.9% |
| Q2 2016 | $120,346,000 | +16.0% | 1,459,897 | +2.0% | 0.07% | +14.5% |
| Q1 2016 | $103,786,000 | -8.3% | 1,431,680 | +8.8% | 0.06% | -6.1% |
| Q4 2015 | $113,219,000 | -8.2% | 1,316,152 | -1.9% | 0.07% | -13.2% |
| Q3 2015 | $123,283,000 | -26.7% | 1,341,342 | -21.6% | 0.08% | -20.8% |
| Q2 2015 | $168,240,000 | +2.1% | 1,710,522 | +2.4% | 0.10% | +1.1% |
| Q1 2015 | $164,767,000 | +8.5% | 1,670,930 | +1.9% | 0.10% | +6.7% |
| Q4 2014 | $151,870,000 | -0.2% | 1,638,988 | +1.4% | 0.09% | -3.3% |
| Q3 2014 | $152,152,000 | +4.9% | 1,616,360 | +0.9% | 0.09% | +7.0% |
| Q2 2014 | $145,081,000 | +6.1% | 1,602,551 | -0.3% | 0.09% | +4.9% |
| Q1 2014 | $136,704,000 | +36.7% | 1,607,362 | +29.2% | 0.08% | +34.4% |
| Q4 2013 | $100,002,000 | +16.8% | 1,244,130 | +11.5% | 0.06% | +8.9% |
| Q3 2013 | $85,612,000 | -3.7% | 1,115,511 | -11.3% | 0.06% | -9.7% |
| Q2 2013 | $88,908,000 | – | 1,257,325 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |